Trichoderma reesei host cells expressing a glucoamylase from Aspergillus fumigatus and methods of use thereof

US10767207B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10767207-B2
Application numberUS-201916281989-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2019
Priority dateDec 11, 2012
Publication dateSep 8, 2020
Grant dateSep 8, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Fungal glucoamylases from Aspergillus fumigatus—expressed in Trichoderma reesei host cells (AfGATR) are provided. Trichoderma reesei host cells express AfGATRs at higher, or at least comparable, levels to natively expressed AfGA Aspergillus fumigatus. AfGATRs, including AfGA1TR and AfGA2TR, exhibit high activity at elevated temperatures and at low pH, so AfGATRs can be used efficiently in a process of saccharification in the presence of alpha-amylase, such as Aspergillus kawachii alpha-amylase (AkAA). AfGATRs advantageously catalyze starch saccharification to an oligosaccharide composition significantly enriched in DP1 (i.e., glucose) compared to the products of saccharification catalyzed by Aspergillus niger glucoamylase (AnGA) or native AfGA expressed in Aspergillus fumigatus. AfGATRs such as AfGA1TR, AfGA2TR or a variant thereof can be used at a lower dosage than AnGA and natively expressed AfGAs to produce comparable levels of glucose.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant Trichoderma reesei ( T. reesei ) host cell expressing an AfGATR having at least 90% sequence identity to SEQ ID NO: 12 or 13, wherein the AfGATR is more thermostable than an AfGA having the same amino acid sequence of AfGATR and wherein the AfGA is expressed in an A. fumigatus host cell. 2. A recombinant AfGATR produced by culturing the host cell of claim 1 in a fermentation medium. 3. The recombinant AfGATR of claim 2 , wherein said AfGATR has at least 70% activity at 74° C. at pH 5.0 over 10 min. 4. The recombinant AfGATR of claim 3 , wherein said AfGATR is an A. fumigatus glucoamylase 1 polypeptide expressed in T. reesei (AfGA1TR). 5. The recombinant AfGA1TR of claim 4 , wherein said AfGA1TR has at least 70% activity over a temperature range of 55° to 74° C. at pH 5.0 over 10 min. 6. The recombinant AfGA1TR of claim 5 , wherein said AfGAT1R has an optimum temperature of about 68° C. 7. The recombinant AfGATR of claim 3 , wherein said AfGATR is an A. fumigatus glucoamylase 2 polypeptide expressed in T. reesei (AfGA2TR). 8. The recombinant AfGA2TR of claim 7 , wherein said AfGA2TR has at least 70% activity over a temperature range of 61° to 74° C. at pH 5.0 over 10 min. 9. The recombinant AfGA2TR of claim 8 , wherein said AfGA2TR has an optimum temperature of about 69° C. 10. The recombinant AfGATR of claim 3 , wherein said AfGATR comprises an amino acid sequence with at least 95% or 99% amino acid sequence identity to SEQ ID NO: 12. 11. The recombinant AfGATR of claim 10 , wherein said AfGATR comprises SEQ ID NO: 12. 12. The recombinant AfGATR claim 3 , wherein said AfGATR consists of an amino acid sequence with at least 99% amino acid sequence identity to SEQ ID NO: 12. 13. The recombinant AfGATR of claim 3 , wherein said AfGATR comprises an amino acid sequence with at least 95% or 99% amino acid sequence identity to SEQ ID NO: 13. 14. The recombinant AfGATR of claim 13 , wherein said AfGATR comprises SEQ ID NO: 13. 15. The recombinant AfGATR of claim 3 , wherein said AfGATR consists of an amino acid sequence with at least 99% amino acid sequence identity to SEQ ID NO: 13. 16. A method of saccharifying a composition comprising starch to produce a composition comprising glucose, wherein said method comprises: (i) contacting a starch composition with the AfGATR of claim 3 ; and (ii) saccharifying the starch composition to produce said glucose composition; wherein said AfGATR catalyzes the saccharification of the composition comprising starch to a composition comprising glucose. 17. The method of claim 16 , wherein said composition comprising glucose is more significantly enriched in DP1 compared to a second composition comprising DP1 produced by Aspergillus niger glucoamylase (AnGA) after 24 hours of saccharification under the same conditions. 18. The method of claim 16 , wherein said composition comprising glucose is enriched in DP1 compared to a second composition comprising DP1 produced by a wild-type AfGA under the same conditions. 19. The method of claim 16 , wherein said AfGATR is AfGATR2 and wherein said composition comprising glucose is enriched in DP1 compared to a second composition comprising DP1 produced by AfGA1TR under the same conditions. 20. The method of claim 16 , wherein the AfGATR is present at an amount about 40%-50% the amount of AnGA, to produce the same DP1 yield after 24 hours of saccharification under the same conditions. 21. The method of claim 16 , wherein the method further comprises contacting a starch composition with an alpha-amylase. 22. The method of claim 21 , wherein the alpha-amylase is AkAA. 23. The method of claim 16 , wherein the method further comprises contacting a starch composition with a pullulanase. 24. The method of claim 16 , further comprising fermenting the glucose composition to produce an End of Fermentation (EOF) product. 25. The method of claim 24 , wherein the EOF product comprises a metabolite. 26. The method of claim 16 , wherein said AfGATR is secreted by said Trichoderma reesei host cell. 27. The method of claim 26 , wherein said host cell further expresses and secretes an alpha-amylase. 28. The method of claim 27 , wherein said host cell further expresses and secretes a pullulanase. 29. The method of claim 26 , wherein said composition comprising starch is contacted with said host cell.

Assignees

Inventors

Classifications

  • Biofuels, e.g. bio-diesel · CPC title

  • C12P19/14Primary

    produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10767207B2 cover?
Fungal glucoamylases from Aspergillus fumigatus—expressed in Trichoderma reesei host cells (AfGATR) are provided. Trichoderma reesei host cells express AfGATRs at higher, or at least comparable, levels to natively expressed AfGA Aspergillus fumigatus. AfGATRs, including AfGA1TR and AfGA2TR, exhibit high activity at elevated temperatures and at low pH, so AfGATRs can be used efficiently in a pro…
Who is the assignee on this patent?
Danisco Us Inc
What technology area does this patent fall under?
Primary CPC classification C12P19/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).